Home › Funds › DAVIS SELECTED ADVISERS › DGX

DAVIS SELECTED ADVISERS position in DGX

QUEST DIAGNOSTICS INC · Health Care

DAVIS SELECTED ADVISERS reported holding 1,325,638 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$309.0M, representing 1.33% of its reported portfolio and ranking #25 among its reported holdings. DAVIS SELECTED ADVISERS has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.33M sh
Reported value held$308.97M
Portfolio Weight1.33%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DAVIS SELECTED ADVISERS's DGX position evolved

DAVIS SELECTED ADVISERS first disclosed a stake in DGX in Q3 2023 at 1,667,698 shares (US$203.2M). The position peaked in Q1 2025 at 2,388,302 shares, worth US$404.1M. Across 13 filings, DAVIS SELECTED ADVISERS increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,325,638 shares valued at US$309.0M — a reduction of -229,974 shares quarter over quarter.. Notable position changes include a 60% increase in Q4 2023 (shares fell 3% over the following quarter), a 43% trim in Q2 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.67M $203.23M New
Q4 2023 2.67M $367.67M Add
Q1 2024 2.38M $316.96M Reduce
Q2 2024 2.39M $327.26M Hold
Q3 2024 2.40M $372.46M Hold
Q4 2024 2.40M $361.65M Hold
Q1 2025 2.39M $404.10M Hold
Q2 2025 1.35M $243.29M Reduce
Q3 2025 1.36M $259.50M Add
Q4 2025 1.59M $275.90M Add
Q1 2026 1.62M $317.06M Add
Q2 2026 1.56M $329.78M Reduce
Q3 2026 1.33M $308.97M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 25 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has DAVIS SELECTED ADVISERS held DGX?

DAVIS SELECTED ADVISERS has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DAVIS SELECTED ADVISERS's current position in DGX?

As of Q3 2026, DAVIS SELECTED ADVISERS holds 1.33M shares of DGX (QUEST DIAGNOSTICS INC), valued at $308.97M, representing 1.33% of its reported portfolio and ranking #25.

Has DAVIS SELECTED ADVISERS been buying or selling DGX?

In the latest 13F filing (Q3 2026), DAVIS SELECTED ADVISERS reduced its position in DGX. The position peaked in Q1 2025 at 2.39M shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.